Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 22, 2025, 13:37
Pregnancy in Sickle Cell Disease: Addressing the Underrecognized Risk of Venous Thromboembolism
American Society of Hematology shared a post on LinkedIn:
“Pregnancy in sickle cell disease carries a high risk of thrombotic complications, yet guidance on anticoagulation remains inconsistent.
Chronic hypercoagulability and prior thrombotic events heighten these risks, making early recognition, individualized care, and preventive strategies essential.
Collaborative, multidisciplinary approaches and evidence-based anticoagulation protocols can help improve outcomes for this vulnerable population.”
Title: Venous Thromboembolism in Sickle Cell Disease: A Critical and Underrecognized Maternal Health Risk
Authors: Sacha Choupa
Read the full article here.
Stay updated with Hemostasis Today.
-
Mar 13, 2026, 17:21Emmanuel J Favaloro: Acquired Hemostasis Disorders Featured in New Issue of Seminars in Thrombosis and Hemostasis
-
Mar 13, 2026, 17:17Paolo Zamboni: New Insights from Australia on Jugular and Azygous Vein Chronic Obstruction
-
Mar 13, 2026, 17:06Srishti Goyal: Can Thalassemia Major Be Prevented?
-
Mar 13, 2026, 16:59Tagreed Alkaltham: Preventing the Risk of Transfusion Reactions Before They Occur
-
Mar 13, 2026, 16:52Giuseppe Lippi: New Insights Into Antiphospholipid Antibodies and Cardiovascular Thrombosis
-
Mar 13, 2026, 16:51Ahmet Dirican: Apixaban vs Rivaroxaban in Acute VTE
-
Mar 13, 2026, 16:47Sinju Thomas: Combined Red Cell and Plasma Exchange for Severe FES in Sickle Cell Disease
-
Mar 13, 2026, 16:44Michael Makris: Lower Bleeding Risk With Apixaban vs Rivaroxaban in Acute Venous Thrombosis
-
Mar 13, 2026, 16:36Muhammad Bilal: Principles and Clinical Uses of the Coombs Test